✦ LIBER ✦

Neurofibromatosis type 1, hyperparathyroidism, and osteosarcoma: interplay?

✍ Scribed by Udi Cinamon; Ilana Avinoach; Moshe Harell

Book ID: 106082371
Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 210 KB
Volume: 259
Category: Article
ISSN: 0302-9530
DOI: 10.1007/s00405-002-0497-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurofibromatosis type 1 and hyperparath

Neurofibromatosis type 1 and hyperparathyroidism. Case report

✍ G. Rovai de Ibáñez; G.A. Méndez; M.J. Pozzo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Neurofibromatosis Type 1

✍ North, Kathryn 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views

Neurofibromatosis 1 (NF1) is an autosomal dominant neurocutaneous disorder with an incidence of approximately 1 in 4000. Cognitive deficits and academic learning difficulties are the most common neurological 'complication' of NF1 in childhood and can be responsible for significant lifetime morbidity

Neurofibromatosis type 1 and pregnancy

✍ Dugoff, Lorraine; Sujansky, Eva 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 1 views

Neurofibromatosis '&pe 1 (NF-1) is an autosomal dominant condition which has markedly variable clinical expression, with manifestations ranging from mild cutaneous lesions to severe orthopedic complications and functional impairment. The current obstetrical literature indicates that women with NF-1

Epidemiology of neurofibromatosis type 1

✍ Friedman, J.M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 1 views

The prevalence of neurofibromatosis type 1 (NF1) is about 1/3,000. There are no known ethnic groups in which NF1 does not occur or is unusually common. The prevalence is somewhat higher in young children than in adults, a difference that probably results at least in part from the early death of some

Neurofibromatosis type 1 growth charts

✍ Clementi, M.; Milani, S.; Mammi, I.; Boni, S.; Monciotti, C.; Tenconi, R. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

Growth abnormalities such as macrocephaly and short stature have been described and are considered a consistent finding in neurofibromatosis type 1 (NF1), one of the most common autosomal dominant disorders in man. We present here a clinical study on the growth profile of a sample of NF1 patients co

Statins, bone, and neurofibromatosis typ

Statins, bone, and neurofibromatosis type 1

✍ Bruce R Korf 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 200 KB